You have 9 free searches left this month | for more free features.

City

Condition

Secondary Hyperparathyroidism (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd. (1)

Collaborator

Intervention

cinacalcet (1)

shr6508 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

shr6508

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Secondary Hyperparathyroidism Trial (SHR6508, Cinacalcet)

Not yet recruiting

Secondary Hyperparathyroidism

SHR6508
Cinacalcet

(no location specified)

Dec 21, 2022